During the Period 2018-2021, Global Dengue Vaccine Market to Grow at a CAGR of 15.05%
ResearchMoz presents professional and in-depth study of "Global Dengue Vaccine Market 2017-2021".
The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1476387
Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking. The scientific community hypothesizes that the DENV evolved in nonhuman primates from where it spread to humans first in Southeast Asia and Africa and then to other parts of the world.
Technavios analysts forecast the global dengue vaccine market to grow at a CAGR of 15.05% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global dengue vaccine market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
View Complete TOC with tables & Figures @ https://www.researchmoz.us/global-dengue-vaccine-market-2017-2021-report.html/toc
Technavio's report, Global Dengue Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
Other prominent vendors
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
Market driver
Rapid growth in disease prevalence
For a full, detailed list, view our report
Market challenge
Regulatory hurdles in vaccine penetration
For a full, detailed list, view our report
Market trend
Licensing deals
For a full, detailed list, view our report
Browse Report @ https://www.researchmoz.us/global-dengue-vaccine-market-2017-2021-report.html
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1476387
Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking. The scientific community hypothesizes that the DENV evolved in nonhuman primates from where it spread to humans first in Southeast Asia and Africa and then to other parts of the world.
Technavios analysts forecast the global dengue vaccine market to grow at a CAGR of 15.05% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global dengue vaccine market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
View Complete TOC with tables & Figures @ https://www.researchmoz.us/global-dengue-vaccine-market-2017-2021-report.html/toc
Technavio's report, Global Dengue Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
Other prominent vendors
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
Market driver
Rapid growth in disease prevalence
For a full, detailed list, view our report
Market challenge
Regulatory hurdles in vaccine penetration
For a full, detailed list, view our report
Market trend
Licensing deals
For a full, detailed list, view our report
Browse Report @ https://www.researchmoz.us/global-dengue-vaccine-market-2017-2021-report.html
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
Comments
Post a Comment